Similar articles

• [Successful treatment of candida sepsis with the oral antimycotic Bay b 5097].

  Malchow H, Seybold D, Lange H, Freund J, Rüger K. Malchow H, et al. Dtsch Med Wochenschr. 1972 Jun 16;97(24):935-8. doi: 10.1055/s-0028-1107471. Dtsch Med Wochenschr. 1972. PMID: 4503519 German. No abstract available.
• [Arterial thromboembolism in candida albicans sepsis. Surgical problems in candida septicemia].

  Sandmann W, Müller E. Sandmann W, et al. Dtsch Med Wochenschr. 1974 Dec 6;99(49):2512-3, 2519-22. Dtsch Med Wochenschr. 1974. PMID: 4611705 German. No abstract available.
• Studies on the activity of a new antimycotic (Bay b 5097) in children.

  Weingärtner L, Sitka U, Patsch R, Gründig C. Weingärtner L, et al. Int J Clin Pharmacol. 1972 Nov;6(4):358-63. Int J Clin Pharmacol. 1972. PMID: 4641850 No abstract available.
• [Septicemia due to candida albicans. Pathogenesis, diagnosis, and chemotherapy].

  Rosin H. Rosin H. Dtsch Med Wochenschr. 1974 Dec 6;99(49):2514, 2526-30. Dtsch Med Wochenschr. 1974. PMID: 4611706 Review. German. No abstract available.
• Candida endophthalmitis: focus on current and future antifungal treatment options.

  Khan FA, Slain D, Khakoo RA. Khan FA, et al. Pharmacotherapy. 2007 Dec;27(12):1711-21. doi: 10.1592/phco.27.12.1711. Pharmacotherapy. 2007. PMID: 18041891 Review.